Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors

MLA

Michael N. Needle, et al. “Phase II Study of Daily Oral Etoposide in Children with Recurrent Brain Tumors and Other Solid Tumors.” Medical and Pediatric Oncology, vol. 29, July 1997, pp. 28–32. EBSCOhost, https://doi.org/10.1002/(sici)1096-911x(199707)29:1<28::aid-mpo5>3.0.co;2-u.

APA

Michael N. Needle, Peter C. Phillips, Joel W. Goldwein, Alisa Herman-Liu, Patricia T. Molloy, J. Russell Geyer, Leslie N. Sutton, & Jean B. Belasco. (1997). Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors. Medical and Pediatric Oncology, 29, 28–32. https://doi.org/10.1002/(sici)1096-911x(199707)29:1<28::aid-mpo5>3.0.co;2-u

Chicago

Michael N. Needle, Peter C. Phillips, Joel W. Goldwein, Alisa Herman-Liu, Patricia T. Molloy, J. Russell Geyer, Leslie N. Sutton, and Jean B. Belasco. 1997. “Phase II Study of Daily Oral Etoposide in Children with Recurrent Brain Tumors and Other Solid Tumors.” Medical and Pediatric Oncology 29 (July): 28–32. doi:10.1002/(sici)1096-911x(199707)29:1<28::aid-mpo5>3.0.co;2-u.